SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-019707
Filing Date
2018-01-25
Accepted
2018-01-25 16:07:02
Documents
4
Period of Report
2018-01-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d496324d8k.htm 8-K 18340
2 EX-1.1 d496324dex11.htm EX-1.1 166682
3 EX-5.1 d496324dex51.htm EX-5.1 8112
4 GRAPHIC g496324cooleyredlogo.jpg GRAPHIC 2644
  Complete submission text file 0001193125-18-019707.txt   198026
Mailing Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS INC (Filer) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36070 | Film No.: 18548346
SIC: 2834 Pharmaceutical Preparations